James A. McNulty

CIK: 0001275857

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INTI

Inhibitor Therapeutics, Inc.

Officer

RENB

RENOVARO INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

INTI
Inhibitor Therapeutics, Inc.
Dec 2, 2024
Gift(G)
Direct
1M shares-
RENB
RENOVARO INC.
Nov 4, 2024
Award(A)
Option to purchase shares of common stock
Direct
121K shares-

		Type	Shares	Price		Ownership
Dec 2, 2024	INTI Inhibitor Therapeutics, Inc.	Gift(G)	1,000,000	-	-	Direct
Nov 4, 2024	RENB RENOVARO INC.	Award(A) Option to purchase shares of common stock	120,968	-	-	Direct

1-2 of 2 transactions

About MCNULTY JAMES A

MCNULTY JAMES A (SEC CIK 0001275857) files insider reports with the SEC as Chief Financial Officer of Inhibitor Therapeutics, Inc. (INTI) and Director of RENOVARO INC. (RENB).

Signal8 holds 3 ownership filings by MCNULTY JAMES A (1 Form 3, 1 Form 4, 1 Form 5), filed between Oct 23, 2024 and Feb 19, 2025. Those filings report 2 transactions, from Nov 4, 2024 to Dec 2, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on MCNULTY JAMES A's filings is in LOS ANGELES, CA.

Recent filings by MCNULTY JAMES A

Dec 2, 2024: Gift of INTI shares (Form 5, code G).
Nov 4, 2024: Grant or award of RENB derivative securities (Form 4, code A).

Other insiders filing for Inhibitor Therapeutics, Inc. (INTI)

Black Robe Capital LLC, 10% Owner
OSMAN RONALD E, Director
Yanez Michelle, Director
SEARS SAMUEL P JR, Director
ODONNELL FRANCIS E JR, Chief Executive Officer
Jerman Michael Allen, Director

How to read Form 4 transaction codes